Development of a peptide-generated antibody to rabbit hemorrhagic disease virus 2 VP60 and its immunohistochemical application in natural cases. [PDF]
Weyna AAW +5 more
europepmc +1 more source
Antibody response of endangered riparian brush rabbits to vaccination against rabbit hemorrhagic disease virus 2. [PDF]
Moriarty ME +12 more
europepmc +1 more source
Rabbit hemorrhagic disease virus 2, 2010-2023: a review of global detections and affected species. [PDF]
Asin J +6 more
europepmc +1 more source
New Insights into Rabbit Viral Diseases. [PDF]
Esteves PJ, Abrantes J, Lopes AM.
europepmc +1 more source
Characterisation of Lagovirus europaeus GI-RHDVs (Rabbit Haemorrhagic Disease Viruses) in Terms of Their Pathogenicity and Immunogenicity. [PDF]
Tokarz-Deptuła B +4 more
europepmc +1 more source
Hepato-ocular crosstalk: Bile acids bridging pathogenesis and therapy. [PDF]
Wang P +7 more
europepmc +1 more source
Surveillance of Wildlife Viruses: Insights from South Australia's Monitoring of Rabbit Haemorrhagic Disease Virus (RHDV GI.1 and GI.2). [PDF]
Peacock DE +3 more
europepmc +1 more source
Causes of morbidity and mortality in wild cottontail rabbits in the eastern United States, 2013-2022. [PDF]
Weyna AAW +12 more
europepmc +1 more source
Coding-complete genome sequences of rabbit hemorrhagic disease virus type 2 detected in 2023 in Washington State indicate a divergent incursion into the United States. [PDF]
Pauszek SJ +8 more
europepmc +1 more source
Primer investigation of RIG-I-like receptors expression in virus infection with the acute character. [PDF]
Lewandowski F +4 more
europepmc +1 more source

